Abstract. Vascular remodeling is the primary cause underlying the failure of angioplasty surgeries, including vascular stenting, transplant vasculopathy and vein grafts. Multiple restenosis-associated proteins and genes have been identified to account for this. In the present study, the functions of ubiquitin-specific peptidase 39 (USP39) were investigated in the context of two vascular remodeling models (a mouse common carotid artery ligation and a pig bilateral saphenous vein-carotid artery interposition graft). USP39 has previously been observed to be upregulated in ligated arteries, and this result was confirmed in the pig vein graft model. In addition, Transwell assay results demonstrated that vascular smooth muscle cell (VSMC) migration was suppressed by lentiviral vector-mediated downregulation of USP39 and enhanced by upregulation of USP39. Furthermore, knockdown of USP39 inhibited VSMC cell proliferation and the expression of cyclin D1 and cyclin-dependent kinase 4, as analyzed via cell counting, MTT assay and western blotting. These results suggest that USP39 may represent a novel therapeutic target for treating vascular injury and preventing vein-graft failure.
Introduction
Vascular remodeling is the primary reason for the failure of angioplasty surgeries, including vascular stenting (1), transplant vasculopathy (2) and vein grafts (3), and represents a major problem for vascular surgical procedures (4) . Coronary artery bypass grafting is widely performed using autologous saphenous vein and internal mammary artery grafts, however, ~50% of patients who undergo the procedure require reoperation 10-15 years later to treat vascular restenosis (5) .
Cell proliferation, migration and apoptosis are the main active processes in vascular remodeling (6) , particularly in vascular smooth muscle cells (VSMCs) (7, 8) . Several animal models of vascular remodeling have been developed to explore the molecular mechanisms responsible for intimal hyperplasia, including wire-insertion, vein bypass grafting and common carotid artery (CCA) ligation models (9) . In a murine CCA ligation model, leukocyte infiltration occurred 1 week after ligation (10) , and smooth muscle cell (SMC)-rich neointima formation and an 80% luminal area reduction was observed 4 weeks after ligation (11) .
Numerous restenosis-associated proteins and genes have been identified, including osteopontin (12) , periostin (13) , connexin 34 (14) and microRNA-21 (15) , however, the association between ubiquitin-specific peptidase 39 (USP39) and restenosis remains to be investigated. USP39 is a 65-kDa SR protein-related member of the ubiquitin-specific protease family, which harbors a deubiquitinating enzyme (DUB) domain (16) . Significantly increased USP39 expression has been observed in breast cancer tissues compared with paracancer tissues and normal tissues (17) and the embryonic zebrafish brain (18) . In vitro removal of small ubiquitin-like modifiers (SUMOs), termed deSUMOlyation, strengthened the proliferation-enhancing effect of USP39 in prostate cancer cells (19) . However, USP39 lacks three residues critical for protease activity and has been revealed to be inactive as a DUB (20) . However, to the best of our knowledge, no previous study to date has assessed the involvement of USP39 in the context of intimal hyperplasia and vascular remodeling. In the present study, the expression and potential novel functions of USP39 in relation to vascular remodeling were investigated. USP39 protein expression levels were determined in ligated arteries in mice and in a pig vein graft model, and the involvement of USP39 in VSMC proliferation and migration was examined. A section of the saphenous vein (~12 cm) from the right leg of each pig was dissected free from surrounding tissue. Two para-sternocleidomastoid muscle longitudinal neck incisions were made and the CCAs were carefully dissected from the internal jugular vein and vagus nerve within the carotid sheath. End-to-end anastomoses of the saphenous vein to CCA were then performed using continuous 7-0 polypropylene sutures. The pigs were sacrificed under general anaesthesia when the grafts were removed using an IV injection of ketamine (>150 mg/kg). Other steps were performed as described previously (12) .
Materials and methods

Animals
Morphometric analysis and immunohistochemistry. The arteries (mice) and veins (pigs) were dissected, embedded in paraffin, and serial 4 µm-sections were taken for morphometric analysis. VSMC migration. Cell migration was assessed by Transwell assay, using the same groups as for the VSMC proliferation assays. Serum free DMEM medium (200 µl) containing 5,000 VSMCs was seeded into the upper chambers of 8 µm-pore size Transwell filters (cat. no. 14831; Corning Incorporated, Corning, NY, USA). In the lower chamber, 500 µl DMEM containing 10% fetal bovine serum was added, which served as a chemoattractant. Non-invading cells on the upper chambers were removed with a cotton-tipped swab following 12 h incubation. The lower sides of the filters were then fixed in 4% paraformaldehyde for 30 min and stained with methylrosanilinium chloride. The invading cells were viewed under an Olympus microscope (Olympus IX51; Olympus Corporation) and counted at x40 magnification (four fields of view for each group). The ability of the cells to invade was expressed as the mean number of cells in the entire field. The assay was performed three times.
Statistical analysis. Data are presented as the mean ± standard deviation. Statistically significant differences were evaluated using Student's t-tests when 2 groups were compared or for multiple comparisons, analysis of variance followed by Student-Newman-Keuls tests. Data were analyzed using Prism 6.0 software (GraphPad Software, Inc., San Diego, CA, USA). P<0.05 was considered to indicate a statistically significant difference. (Fig. 1A) resulted in vascular remodeling. The thickening of ligated arteries in mice was assessed 2 and 4 weeks following surgery (Fig. 1B) . Morphometric analysis of hematoxylin and eosin ( Fig. 2A) and Masson's trichrome-stained sections ( Fig. 2B ) was performed. Immunohistochemical analysis revealed positive staining for USP39, which was predominantly localized in the neointimal layer, and was also present in the nucleus (Fig. 2C) . Analysis of mice carotid artery sections confirmed that the neointima thickness was increased in the ligated arteries 2 and 4 weeks after surgery, compared with the non-ligated control arteries (P=0.0125 and P=0.0046, respectively; Fig. 2D ). Significantly increased USP39 protein expression was observed at 2 and 4 weeks in ligated carotid arteries compared with the non-ligated control arteries (P=0.0136 and P=0.0014, respectively; Fig. 2E ) and USP39 was more abundant at 4 weeks in ligated carotid arteries compared with at 2 weeks (Fig. 2E ).
Results
USP39 is expressed in the ligated arterial wall. CCA ligation
USP39 expression is elevated during restenosis in pig vein
grafts. The thickening of vein-grafts in the pig was assessed at 2 and 4 weeks after surgery (Fig. 3A) . USP39 protein expression levels in the pig vein grafts at different time points following transplantation confirmed the results observed in the ligated mouse carotid arteries (Fig. 3B) , and there were significantly more USP39-positive cells in the grafts at 2 and 4 weeks after surgery compared with the baseline levels prior to the operation (P=0.0028 and P=0.0023, respectively; Fig. 3C ). (17) previously reported that RNA interference-mediated downregulation of USP39 markedly reduced the proliferation and colony-forming ability of MCF-7 cells, and induced G0/G1-phase arrest and apoptosis. The effect of overexpression (Fig. 4A) and knockdown (Fig. 4B ) of USP39 on the USP39 protein was determined in the present study. USP39-73 siRNA was selected as the most effective siRNA at knocking down USP39 protein levels (Fig. 4B) and was, therefore, used for further experiments. Knockdown of USP39 in VSMCs inhibited cyclinD1 and CDK4 protein expression compared with transfection with control siRNA (Fig. 4C) , which are essential proteins for G1/S phase transformation. Furthermore, USP39 knockdown in VSMCs significantly reduced proliferation compared with cells transfected with control siRNA (P=0.0238; Fig. 4D ). The growth rate of VMSCs was demonstrated to be significantly suppressed by USP39 knockdown compared with cells transfected with control siRNA at 3 and 5 days (P=0.0478 and P=0.0002, respectively; Fig. 4E ) via an MTT assay. However, USP39 overexpression had no significant effect on cell growth rate compared with cells transfected with empty vector (P>0.05; Fig. 4F ).
Knockdown of USP39 inhibits VSMC proliferation and the expression of cyclin D1 and CDK4. Wang et al
USP39 is associated with VSMC migration. The migration of VSMC is a crucial event in the pathogenesis of vascular diseases and is characterized by intimal thickening (22) . In the present study, VSMC migration was suppressed by knockdown of USP39 compared with transfection with control siRNA (P=0.0111; Fig. 5A ) and migration was significantly increased in VSMCs overexpressing USP39 compared with control cells (P=0.0028; Fig. 5B and C) . 
Discussion
The ubiquitin specific protease USP39 lacks three residues critical for protease activity, and thus lacks DUB activity despite the presence of a DUB domain (17, 20) . USP39 has previously been suggested to be involved in controlling cell growth in the pituitary gland, thus maintaining pituitary homeostasis in zebrafish (18) . However, no exact mechanisms, specific substrates or other functions of USP39 have been identified.
To the best of our knowledge, the present study provides the first evidence for an association between USP39 expression and remodeling in ligated arteries and vein grafts, and USP39 may be involved in this pathological process in vein grafts and ligated arteries. The mouse carotid artery ligation and pig vein graft models closely resemble human venous bypass graft failure in terms of their morphological characteristics and development (23, 24) , and are thus useful for exploring the potential pathogenesis and novel therapies.
It has previously been reported that USP39 silencing affects spindle checkpoint function and cytokinesis by reducing Aurora B kinase levels (20) . Furthermore, inhibition of USP39 induced G0/G1-phase arrest and apoptosis in breast cancer cells (17) . Similarly, cyclin D1 and CDK4 protein expression levels, which maintain the cell cycle process, were decreased in USP39-knockout VSMCs compared with control cells, and VSMC proliferation was also significantly reduced by USP39-knockdown in the present study. Although it is not possible to conclude that USP39 has a direct effect on VSMC proliferation from these results alone, it appears to be associated with SMC proliferation, and may provide a novel target for the treatment of vascular restenosis. Vascular remodeling is the structural reorganization of a vessel and involves multiple cell activities, including SMC proliferation, migration and extracellular membrane restriction (7) . The present study also demonstrated that VSMC migration was suppressed by downregulation of USP39 and enhanced by upregulation of USP39. The proliferation and migration of VSMCs is a key event in the pathogenesis of vascular diseases and is characterized by intimal thickening, which is most commonly seen in atherosclerosis, vascular rejection, restenosis following vein grafting and coronary intervention (22, 25, 26) . Multiple factors that affect the proliferation and migration of VSMCs. USP39 appears to be involved in proliferation and migration, but further studies are needed to assess potential underlying molecular mechanisms.
Once vascular injury occurs, the exposed subendothelial matrix rapidly attracts platelets and leukocytes, and infiltrated leukocytes may then release inflammatory cytokines several days following injury (12, 24) . Inflammation is believed to be associated with altered gene expression during the early stage of vascular remodeling (27) (28) (29) . In the present study, USP39 expression was significantly increased in pig vein grafts and ligated mouse carotid arteries at 2 weeks after surgery.
The results of the present study indicate that USP39 may be involved in the early stages and development of vascular injury. However, inflammation and vascular remodeling are continuous processes, and specific mechanisms of USP39 throughout these processes require further investigation.
The present study provides the first evidence for an association between high USP39 protein levels and the development of vascular remodeling. USP39 regulates the cell cycle and affects proliferation and migration of VSMCs. USP39 may thus represent a novel therapeutic target for treating vascular injury and preventing vein-graft failure.
